XML 38 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments
9 Months Ended
Oct. 01, 2016
Business Segments  
Business Segments

The Company has the following three reportable segments:

 

●  Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients to the manufacturers of consumer products in various industries including the nutritional supplement, food and beverage and animal health industries.
●  Core standards and contract services segment includes supply of phytochemical reference standards, which are small quantities of plant-based compounds typically used to research an array of potential attributes, reference materials and related contract services.

●  Scientific and regulatory consulting segment which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage potential health and regulatory risks.

 

The “Other” classification includes corporate items not allocated by the Company to each reportable segment. Further, there are no intersegment sales that require elimination. The Company evaluates performance and allocates resources based on reviewing gross margin by reportable segment.

 

Three months ended
October 1, 2016
     Core Standards and  Scientific and      
   Ingredients  Contract
Services
  Regulatory
Consulting
      
   segment  segment  segment  Other  Total
                          
Net sales  $2,663,095   $2,052,135   $292,220   $—     $5,007,450 
Cost of sales   1,287,421    1,548,268    129,291    —      2,964,980 
                          
Gross profit   1,375,674    503,867    162,929    —      2,042,470 
                          
Operating expenses:                         
Sales and marketing   199,130    245,255    3,600    —      447,985 
Research and development   760,299    12,500    —      —      772,799 
General and administrative   —      —      —      1,768,402    1,768,402 
Operating expenses   959,429    257,755    3,600    1,768,402    2,989,186 
                          
Operating income (loss)  $416,245   $246,112   $159,329   $(1,768,402)  $(946,716)

 

Three months ended
October 3, 2015
     Core Standards and  Scientific and      
   Ingredients  Contract Services  Regulatory
Consulting
      
   segment  segment  segment  Other  Total
                          
Net sales  $4,146,597   $1,875,296   $265,416   $—     $6,287,309 
Cost of sales   2,157,183    1,533,402    115,094    —      3,805,679 
                          
Gross profit   1,989,414    341,894    150,322    —      2,481,630 
                          
Operating expenses:                         
Sales and marketing   259,874    287,901    3,103    —      550,878 
Research and development   188,690    —      —      —      188,690 
General and administrative   —      —      —      1,564,932    1,564,932 
Operating expenses   448,564    287,901    3,103    1,564,932    2,304,500 
                          
Operating income (loss)  $1,540,850   $53,993   $147,219   $(1,564,932)  $177,130 

 

Nine months ended
October 1, 2016
     Core Standards and  Scientific and      
   Ingredients  Contract
Services
  Regulatory Consulting      
   segment  segment  segment  Other  Total
                          
Net sales  $13,505,470   $7,110,783   $552,721   $—     $21,168,974 
Cost of sales   6,420,972    4,781,539    345,127    —      11,547,638 
                          
Gross profit   7,084,498    2,329,244    207,594    —      9,621,336 
                          
Operating expenses:                         
Sales and marketing   930,573    749,165    11,000    —      1,690,738 
Research and development   1,961,097    27,500    —      —      1,988,597 
General and administrative   —      —      —      6,063,520    6,063,520 
Operating expenses   2,891,670    776,665    11,000    6,063,520    9,742,855 
                          
Operating income (loss)  $4,192,828   $1,552,579   $196,594   $(6,063,520)  $(121,519)

 

 

Nine months ended
October 3, 2015
     Core Standards and  Scientific and      
   Ingredients  Contract
Services
  Regulatory
Consulting
      
   segment  segment  segment  Other  Total
                          
Net sales  $10,238,574   $6,546,816   $864,270   $—     $17,649,660 
Cost of sales   5,629,564    4,742,480    397,670    —      10,769,714 
                          
Gross profit   4,609,010    1,804,336    466,600    —      6,879,946 
                          
Operating expenses:                         
Sales and marketing   832,779    935,237    8,387    —      1,776,403 
Research and development   485,195    —      —      —      485,195 
General and administrative   —      —      —      5,531,362    5,531,362 
Operating expenses   1,317,974    935,237    8,387    5,531,362    7,792,960 
                          
Operating income (loss)  $3,291,036   $869,099   $458,213   $(5,531,362)  $(913,014)

 

 

      Core Standards and  Scientific and      
At October 1, 2016  Ingredients  Contract
Services
  Regulatory
Consulting
      
   segment  segment  segment  Other  Total
                      
Total assets  $12,051,865   $ 3,645,554  $ 166,027  $2,900,244   $18,763,690 
                      

 

      Core Standards and  Scientific and      
At January 2, 2016  Ingredients  Contract
Services
  Regulatory
Consulting
      
   segment  segment  segment  Other  Total
                      
Total assets  $9,105,502   $ 3,306,624  $ 111,765  $6,225,318   $18,749,209 
                      

 

Disclosure of major customers

 

Major customers who accounted for more than 10% of the Company’s total sales were as follows:

 

   Percentage of the Company's Total Sales
   Three Months Ended  Nine Months Ended
Major Customers  Oct. 1, 2016  Oct. 3, 2015  Oct. 1, 2016  Oct. 3, 2015
             
Customer D (Ingredients and Core segment)   12.3%   *    *    * 
Customer C (Ingredients segment)   *    *    24.5%   * 
Customer B (Ingredients segment)   *    19.1%   *    13.8%
                     
* Represents less than 10%.                    

 

Major customers who accounted for more than 10% of the Company’s total trade receivables were as follows:

 

   Percentage of the Company's Total Trade Receivables
       
Major Customers   At October 1, 2016    At January 2, 2016 
           
Customer D (Ingredients and Core segment)   *    22.8%
Customer C (Ingredients segment)   48.8%   * 
Customer A (Ingredients segment)   *    14.7%
           
* Represents less than 10%.